Registration Options

Register for the meeting.

Session Time and Location

Date: Tuesday, 04/26/2022

Time: 3:00 PM (view in the schedule)

Room: TBD

Target Audience

If you are a pharmacist, nurse practitioner or other healthcare professional involved in the comprehensive medication management of psychiatric and/or neurological patients, we invite you to participate in this online course.

Session Summary

Symptoms of psychosis, including visual hallucinations and delusions, occur in up to 90% of patients with Parkinson’s Disease (PD), Parkinson’s Disease dementia (PDD), and dementia with Lewy bodies (DLB). The theme across these disorders includes the presence of alpha-synuclein pathology, and the pathophysiologic impact on converging brain networks. Identifying and managing these symptoms of psychosis represent a considerable challenge. Therapeutic limitations arise from the paucity of efficacious agents, deterioration in motor function due to dopamine receptor antagonism from conventional antipsychotics, interaction of sleep dysfunction and psychosis presentation, among other factors. As the management of psychosis can be complicated, many of these patients may seek specialized neuropsychiatric care; thus, psychiatric and neurologic pharmacists should be familiar with treatment strategies and pharmacotherapy utilized based on patient diagnosis.

Faculty Information and Disclosures

Learning Objectives

  1. Describe clinical presentation of Parkinson’s Disease (PD), PD dementia (PDD), and dementia with Lewy bodies (DLB).
  2. Discuss prevalence and qualitative information related to psychosis in PD, dementia with Lewy bodies, and other atypical parkinsonian syndromes.
  3. Identify treatment strategies to manage psychotic symptoms in relationship to safety, efficacy, and currently available evidence.
  4. Outline information related to pimavanserin and its suggested indication for management of psychosis in dementia-related psychosis.

Continuing Education Credit and Disclosures

ACPEThe College of Psychiatric and Neurologic Pharmacists is accredited by the Accreditation Council for Pharmacy Education as a provider of continuing pharmacy education.